DAIC

APRIL 11, 2024

The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs. of patients who received IVUS and 70.1%

Peripheral Arterial Disease 116

Peripheral Arterial Disease Ultrasound Angioplasty Plaque 116

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

Traditional treatments like plain old balloon angioplasty (POBA) have limited success due to high restenosis rates. Drug-coated balloon angioplasty (DCBA) has emerged as a promising alternative, locally delivering antiproliferative drugs like paclitaxel to reduce restenosis. ResultsSixteen meta-analyses were included.

Angioplasty 52

Angioplasty Peripheral Arterial Disease Outcomes Research 52

DAIC

NOVEMBER 8, 2024

Venita Chandra, director of vascular surgery, Stanford University School of Medicine, showed that DA followed by DCB achieved a significantly lower provisional stent rate with comparable safety and efficacy outcomes compared to standard predilatation prior to DCB, making it a viable alternative for treating long and highly calcified lesions.

Stent 52

Stent Stents Angioplasty Peripheral Arterial Disease 52

DAIC

JANUARY 9, 2024

Improvements in outcomes following peripheral vascular intervention have lagged compared to other endovascular treatments, such as percutaneous coronary intervention. Ongoing collaboration among these specialties is paramount to improving outcomes for patients worldwide.” Tam, MD, MBA, FSIR.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Ultrasound Angioplasty Interventional Cardiology 105

Circulation

NOVEMBER 11, 2024

This study investigates the association between VTRNA2-1 promoter methylation and clinical outcomes in PAD patients requiring revascularization.Hypothesis:VTRNA2-1 promoter methylation status is associated with clinical outcomes in PAD patients requiring revascularization.Methods:A total of 133 PAD patients requiring revascularization were enrolled.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Biomarkers Angioplasty Atherosclerosis 40

Dr. Anish Koka

JULY 23, 2023

Most have gotten used to egregiously bad coverage of current events that fills the pages of today’s New York Times, but even by their now very low standards a recent telling of a story about peripheral artery disease was very bad. The Times also briefly touches on some other patients of Mustapha who had bad outcomes.

Vascular Care 52

Vascular Care Outpatient Peripheral Arterial Disease Stent 52

Dr. Anish Koka

MAY 16, 2023

Soviet biologist Trofim Lysenko famously rejected the objective reality of Mendelian genetics because it clashed with the Marxist philosophy that the environment, not genetics, was the primary determinant of outcomes. years of age, P <0.001), cerebral or peripheral artery disease (6.2% years of age versus 59.0±8.4

Chest Pain 52

Chest Pain Coronary Artery Disease Cancer Heart Attack 52